on INNATE PHARMA (EPA:IPH)
Innate Pharma unveils its financial calendar for 2025
Innate Pharma SA, a company listed on Euronext Paris and Nasdaq, has published its financial calendar for 2025. The communication of the annual results for 2024 is scheduled for March 27, 2025. Then, the revenue and cash position for the first quarter of 2025 will be revealed on May 13, 2025, followed by the Annual General Meeting on May 22. The half-year results for 2025 will be published on September 17, and the third quarter data on November 13. These publications will always precede the opening of the market in Central European Time. Any additional information is available on the company's website.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news